Invasive lobular breast cancer: Focus on prevention, genetics, diagnosis, and treatment. Read more about Invasive lobular breast cancer: Focus on prevention, genetics, diagnosis, and treatment.
Dexamethasone to prevent everolimus-induced stomatitis (Alliance MIST Trial: A221701). Read more about Dexamethasone to prevent everolimus-induced stomatitis (Alliance MIST Trial: A221701).
Mechanisms and clinical course of cardiovascular toxicity of cancer treatment I. Oncology. Read more about Mechanisms and clinical course of cardiovascular toxicity of cancer treatment I. Oncology.
Fibronectin in malignancy: Cancer-specific alterations, protumoral effects, and therapeutic implications. Read more about Fibronectin in malignancy: Cancer-specific alterations, protumoral effects, and therapeutic implications.
Current and Emerging Perspectives on Immunotherapy for Melanoma. Read more about Current and Emerging Perspectives on Immunotherapy for Melanoma.
A 46-Year-Old Asian Woman With Liver Mass. Read more about A 46-Year-Old Asian Woman With Liver Mass.
Symptom management during the radiation oncology treatment course: a practical guide for the oncology clinician. Read more about Symptom management during the radiation oncology treatment course: a practical guide for the oncology clinician.
Clinical practice experience with NovoTTF-100A™ system for glioblastoma: The Patient Registry Dataset (PRiDe). Read more about Clinical practice experience with NovoTTF-100A™ system for glioblastoma: The Patient Registry Dataset (PRiDe).
Characterization and management of dermatologic adverse events with the NovoTTF-100A System, a novel anti-mitotic electric field device for the treatment of recurrent glioblastoma. Read more about Characterization and management of dermatologic adverse events with the NovoTTF-100A System, a novel anti-mitotic electric field device for the treatment of recurrent glioblastoma.
A roundtable discussion on the clinical challenges and options for the treatment of glioblastoma: introducing a novel modality, TTFields. Read more about A roundtable discussion on the clinical challenges and options for the treatment of glioblastoma: introducing a novel modality, TTFields.
